SNSE
Sensei Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.85
−22.28%Price chart
Jun 11Jun 16Jun 22Jun 25Jun 30Jul 6Jul 9Jul 14
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
Market Cap
$18.57M
MomentumView details →
1D Return
−22.28%
YTD Return
+210.40%
RSI (14)
68.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
Market Cap
$18.57M
RSI (14)
68.9
MomentumView details →
1D Return
−22.28%
YTD Return
+210.40%
SummaryUpdated Mar 1, 2026
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) is a clinical-stage biopharmaceutical company founded in 1999 and headquartered in Rockville, Maryland. Originally incorporated as Panacea Pharmaceuticals, Inc., the company went public in February 2021 and focuses on developing innovative immunotherapies for cancer treatment. The company operates two proprietary technology platforms designed to harness the body's immune system to fight cancer, representing a next-generation approach to oncology treatment.
Similar companies
Latest newsMore news →